Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Cisplatin 49 Capecitabine 41 apatinib 34 Gemcitabine 33 Oxaliplatin 32 Cyclophosphamide 31 Radiotherapy 29 Paclitaxel 29 Carboplatin 29 tislelizumab 27 Irinotecan 27 Drug Therapy 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 fludarabine 18 Surgical Procedures, Operative 17 Nivolumab 17 pembrolizumab 16 Exercise 16 Metformin 15 camrelizumab 14 S 1 (combination) 14 Radiation 14 Pemetrexed 13 Control Groups 12 anlotinib 11 Leucovorin 11 toripalimab 10 Vinorelbine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Alginates × Clear all

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡